CEO Ira Pastor has revealed their first stage, named 'First In Human Neuro-Regeneration & Neuro-Reanimation' was slated to be a non-randomized, single group 'proof of concept' study.
The team planned to examine individuals aged 15-65 declared brain dead from a traumatic brain injury using MRI scans, in order to look for possible signs of brain death reversal.
Bioquark says that brain death can be reversed by harvesting stem cells from the patient’s own blood then injecting them back into the subject, along with a dose of peptides to the spinal cord.
Patients would then undergo 15 days of laser nerve stimulation while being monitored by an MRI scanner. Bioquark claims that this should be enough to reverse brain death.
Source: dailymail.co.uk
